Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

Screening, referral and treatment for depression in patients with coronary heart disease

In 2003, an Expert Working Group of the National Heart Foundation of Australia (NHFA) issued a position statement on the relationship between “stress” and heart disease. They concluded that depression was an important independent risk factor for first and recurrent coronary heart disease (CHD) events.1 Here, we provide an update on evidence obtained since 2003 regarding depression in patients with CHD, and include guidance for health professionals on screening and treatment for depression in these patients. Our statement refers to depression in general (mild, moderate and severe), as all grades of depression have an impact on CHD prognosis. The process for developing this consensus statement is described in Box 1. Treatment decisions should take into account the individual clinical circumstances of each patient.


The prevalence of depression is high in patients with CHD. Rates of major depressive disorder of around 15% have been reported in patients after myocardial infarction (MI) or coronary artery bypass grafts.3,